Side Effects: The Details Hiding in Plain Sight - Scorecard - MDSpire

Side Effects: The Details Hiding in Plain Sight

  • By

  • Kerri Miller

  • March 9, 2026

  • 6 min

Share

Clinical Scorecard: Side Effects: The Details Hiding in Plain Sight

At a Glance

CategoryDetail
ConditionMinocycline-induced hyperpigmentation
Key MechanismsIron-chelated minocycline complexes and melanin deposition in dermal macrophages
Target PopulationPatients on long-term minocycline for rosacea
Care SettingDermatology

Key Highlights

  • Minocycline-induced hyperpigmentation affects 2.4% to 14.8% of patients.
  • Misdiagnosis often occurs as post-inflammatory changes or aging.
  • Stopping minocycline can resolve some types of hyperpigmentation.
  • Teeth staining from minocycline is permanent.
  • Guidelines recommend against long-term use of minocycline.

Guideline-Based Recommendations

Diagnosis

  • Evaluate skin changes in patients on minocycline for over 6-12 months.

Management

  • Discontinue minocycline if hyperpigmentation is observed.

Monitoring & Follow-up

  • Regular skin assessments for patients on long-term minocycline.

Risks

  • Potential for irreversible pigmentation changes.

Patient & Prescribing Data

Patients with rosacea on minocycline for extended periods.

Long-term minocycline use may lead to significant skin changes.

Clinical Best Practices

  • Consider alternative treatments for rosacea to avoid long-term minocycline use.
  • Educate patients about the risks of prolonged minocycline therapy.

References

Original Source(s)

Related Content